BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gorelenkova Miller O, Behring JB, Siedlak SL, Jiang S, Matsui R, Bachschmid MM, Zhu X, Mieyal JJ. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease. Antioxid Redox Signal 2016;25:967-82. [PMID: 27224303 DOI: 10.1089/ars.2015.6598] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Brücksken KA, Loreto Palacio P, Hanschmann E. Thiol Modifications in the Extracellular Space—Key Proteins in Inflammation and Viral Infection. Front Immunol 2022;13:932525. [DOI: 10.3389/fimmu.2022.932525] [Reference Citation Analysis]
2 Ritiu SA, Rogobete AF, Sandesc D, Bedreag OH, Papurica M, Popovici SE, Toma D, Ivascu RI, Velovan R, Garofil DN, Corneci D, Bratu LM, Pahontu EM, Pistol A. The Impact of General Anesthesia on Redox Stability and Epigenetic Inflammation Pathways: Crosstalk on Perioperative Antioxidant Therapy. Cells 2022;11:1880. [PMID: 35741011 DOI: 10.3390/cells11121880] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Guo Y, Liu Y, Zhao S, Xu W, Li Y, Zhao P, Wang D, Cheng H, Ke Y, Zhang X. Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages. Nat Commun 2021;12:7094. [PMID: 34876574 DOI: 10.1038/s41467-021-27428-9] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
4 Dolatshahi M, Ranjbar Hameghavandi MH, Sabahi M, Rostamkhani S. Nuclear factor-kappa B (NF-κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration. Eur J Neurosci 2021. [PMID: 33884689 DOI: 10.1111/ejn.15242] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Ogata FT, Branco V, Vale FF, Coppo L. Glutaredoxin: Discovery, redox defense and much more. Redox Biol 2021;43:101975. [PMID: 33932870 DOI: 10.1016/j.redox.2021.101975] [Reference Citation Analysis]
6 Burns M, Rizvi SHM, Tsukahara Y, Pimentel DR, Luptak I, Hamburg NM, Matsui R, Bachschmid MM. Role of Glutaredoxin-1 and Glutathionylation in Cardiovascular Diseases. Int J Mol Sci 2020;21:E6803. [PMID: 32948023 DOI: 10.3390/ijms21186803] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
7 Guo L, Chen S, Liu Q, Ren H, Li Y, Pan J, Luo Y, Cai T, Liu R, Chen J, Wang Y, Wang X, Huang N, Li J. Glutaredoxin 1 regulates macrophage polarization through mediating glutathionylation of STAT1. Thorac Cancer 2020;11:2966-74. [PMID: 32893965 DOI: 10.1111/1759-7714.13647] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Daiber A, Chlopicki S. Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies. Free Radical Biology and Medicine 2020;157:15-37. [DOI: 10.1016/j.freeradbiomed.2020.02.026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 52] [Article Influence: 14.5] [Reference Citation Analysis]
9 Verma A, Ray A, Bapat D, Diwakar L, Kommaddi RP, Schneider BL, Hirsch EC, Ravindranath V. Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice. Mov Disord 2020;35:1843-53. [PMID: 32618039 DOI: 10.1002/mds.28190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Jiang D, Peng Y. The protective effect of decoction of Rehmanniae via PI3K/Akt/mTOR pathway in MPP+-induced Parkinson's disease model cells. J Recept Signal Transduct Res 2021;41:74-84. [PMID: 32611232 DOI: 10.1080/10799893.2020.1787445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Bagwe-parab S, Kaur G. Molecular targets and therapeutic interventions for iron induced neurodegeneration. Brain Research Bulletin 2020;156:1-9. [DOI: 10.1016/j.brainresbull.2019.12.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Matsui R, Ferran B, Oh A, Croteau D, Shao D, Han J, Pimentel DR, Bachschmid MM. Redox Regulation via Glutaredoxin-1 and Protein S-Glutathionylation. Antioxid Redox Signal 2020;32:677-700. [PMID: 31813265 DOI: 10.1089/ars.2019.7963] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
13 Yura Y, Chong BSH, Johnson RD, Watanabe Y, Tsukahara Y, Ferran B, Murdoch CE, Behring JB, McComb ME, Costello CE, Janssen-Heininger YMW, Cohen RA, Bachschmid MM, Matsui R. Endothelial cell-specific redox gene modulation inhibits angiogenesis but promotes B16F0 tumor growth in mice. FASEB J 2019;33:14147-58. [PMID: 31647879 DOI: 10.1096/fj.201900786R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
14 Steven S, Frenis K, Oelze M, Kalinovic S, Kuntic M, Bayo Jimenez MT, Vujacic-Mirski K, Helmstädter J, Kröller-Schön S, Münzel T, Daiber A. Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease. Oxid Med Cell Longev 2019;2019:7092151. [PMID: 31341533 DOI: 10.1155/2019/7092151] [Cited by in Crossref: 117] [Cited by in F6Publishing: 182] [Article Influence: 39.0] [Reference Citation Analysis]
15 Ma D, Liu X, Liu J, Li M, Chen L, Gao M, Xu W, Yang Y. Long-term liraglutide ameliorates nigrostriatal impairment via regulating AMPK/PGC-1a signaling in diabetic mice. Brain Res 2019;1714:126-32. [PMID: 30826352 DOI: 10.1016/j.brainres.2019.02.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wang J, Zhang B, Jiao Y, Xu Z, Qian B, Wang Q. Involvement of prostatic interstitial cells of Cajal in inflammatory cytokines-elicited catecholamines production: Implications for the pathophysiology of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Biochemical and Biophysical Research Communications 2018;503:420-7. [DOI: 10.1016/j.bbrc.2018.04.050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Cheng CY, Pho QH, Wu XY, Chin TY, Chen CM, Fang PH, Lin YC, Hsieh MF. PLGA Microspheres Loaded with β-Cyclodextrin Complexes of Epigallocatechin-3-Gallate for the Anti-Inflammatory Properties in Activated Microglial Cells. Polymers (Basel) 2018;10:E519. [PMID: 30966553 DOI: 10.3390/polym10050519] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
18 Gorelenkova Miller O, Mieyal JJ. Critical Roles of Glutaredoxin in Brain Cells-Implications for Parkinson's Disease. Antioxid Redox Signal 2019;30:1352-68. [PMID: 29183158 DOI: 10.1089/ars.2017.7411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Gorelenkova Miller O, Cole KS, Emerson CC, Allimuthu D, Golczak M, Stewart PL, Weerapana E, Adams DJ, Mieyal JJ. Novel chloroacetamido compound CWR-J02 is an anti-inflammatory glutaredoxin-1 inhibitor. PLoS One 2017;12:e0187991. [PMID: 29155853 DOI: 10.1371/journal.pone.0187991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol 2017;13:94-162. [PMID: 28577489 DOI: 10.1016/j.redox.2017.05.007] [Cited by in Crossref: 154] [Cited by in F6Publishing: 163] [Article Influence: 30.8] [Reference Citation Analysis]
21 Matsui R, Watanabe Y, Murdoch CE. Redox regulation of ischemic limb neovascularization - What we have learned from animal studies. Redox Biol 2017;12:1011-9. [PMID: 28505880 DOI: 10.1016/j.redox.2017.04.040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]